Response to: Correspondence on ‘Cardiovascular toxicities associated with bispecific T-cell engager therapy’ by Noguchi et al

Recent Posts

Impact of PORT on Outcomes in Advanced TESCCSeptember 30, 2024
BTN3A1 Drives Vγ9Vδ2 T Cell Exhaustion in Cervical CancerSeptember 30, 2024
Inhibition of NF-κB/HIF-1α Pathway by Tyrosol in CRCSeptember 30, 2024
Nomilin Targets PI3K/Akt Pathway in TNBCSeptember 30, 2024
Optimizing HCC Prognostic Precision with PWR ALBI and PALBISeptember 30, 2024

Recent Comments

No comments to show.